Publicly Traded Cannabis Stock News

FDA Expands GW Pharma’s Epidiolex Label

FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex – Age-range for all EPIDIOLEX indications expanded to include patients one year of age and...
- August 3rd, 2020 at 7:35 am

American Cannabis Operator Stocks Soar 27% in July

Adding to a 29% gain in Q2 despite a pullback in June, the American Cannabis Operator Index rocketed higher in July, increasing 26.7% to 34.53: The index, which launched at the...
- August 2nd, 2020 at 6:00 pm

Emerald Health to Sell Quebec Subsidiary for $21 Million

Emerald Health Therapeutics and Quinto Resources Enter into Share Purchase Agreement for Sale of Quebec Cannabis Business Vancouver, British Columbia–(Newsfile Corp. – July 31, 2020) – Emerald Health Therapeutics,...
- July 31st, 2020 at 7:41 am

How to Assess Cannabis Operator Intangible Assets

Intangible Assets in the Cannabis Industry – Measuring the Success of Acquisitions Guest Post by Noam Hirschberger, CFA, CVA, Principal, Co-Lead of Cannabis Practice at PKF O’Connor Davies In the...
- July 29th, 2020 at 10:54 am

Hawthorne Gardening Q3 Sales Grow 72% to $303 Million

ScottsMiracle-Gro Announces Third Quarter Financial Results, Increased Fiscal 2020 Guidance and Approval of Special Dividend Company-wide third quarter sales increase 28% including Hawthorne growth of 72% U.S. Consumer sales...
- July 29th, 2020 at 7:51 am

Curaleaf Closes Grassroots Cannabis Acquisition

Curaleaf Completes the Acquisition of Grassroots Creating the World’s Largest Cannabis Company Market Leading U.S. Presence Across 23 States with Over 135 Dispensary Locations and Licenses Mitchell Kahn, Grassroots...
- July 23rd, 2020 at 8:40 am

Curaleaf Boosts Equity Offering to C$34 Million

Curaleaf Holdings Announces Closing of C$34.06 Million Private Placement of Subordinate Voting Shares WAKEFIELD, Mass., July 21, 2020 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or...
- July 21st, 2020 at 9:29 am

Organigram Q3 Revenue Declines 27% to $18 Million

Organigram Reports Third Quarter Fiscal 2020 Results Net revenue of $18.0 million compared to $24.8 million in Q3 2019 Generated positive cash flow from operations of $8.5 million as...
- July 21st, 2020 at 7:00 am

Neptune Raises $12.7 Million Selling Shares at $2.65

Neptune Wellness Solutions Inc. Announces US$12.65 Million Registered Direct Offering LAVAL, QC, July 13, 2020 /PRNewswire/ – Neptune Wellness Solutions Inc. (“NEPT” or the “Company”) (TSX: NEPT) (NASDAQ: NEPT),...
- July 13th, 2020 at 9:32 am